Compare ABOS & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABOS | FCAP |
|---|---|---|
| Founded | 1996 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.0M | 191.6M |
| IPO Year | 2021 | 1998 |
| Metric | ABOS | FCAP |
|---|---|---|
| Price | $2.58 | $57.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 294.2K | 1.8K |
| Earning Date | 05-12-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | N/A | ★ 36.97 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $7,170,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.81 |
| Revenue Growth | N/A | ★ 1.57 |
| 52 Week Low | $0.97 | $33.88 |
| 52 Week High | $3.60 | $71.00 |
| Indicator | ABOS | FCAP |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 62.81 |
| Support Level | $2.24 | $50.24 |
| Resistance Level | $3.02 | $63.70 |
| Average True Range (ATR) | 0.14 | 0.82 |
| MACD | 0.01 | 0.32 |
| Stochastic Oscillator | 43.64 | 92.21 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.